HB 5386 – Connecticut

Status: Inactive / Dead
Year Introduced: 2022
Link: https://www.cga.ct.gov/asp/cgabillstatus/cgabillstatus.asp?selBillType=Bill&bill_num=HB05386&which_year=2022

To place a cap on costs for epinephrine cartridge injectors. This bill (1) requires certain individual and group health insurance policies that cover outpatient prescription drugs to cover at least one epinephrine cartridge (dual-pack) injector (e.g., EpiPen) and (2) caps an insured’s cost sharing (e.g., copayment, coinsurance, or deductible) for the injector at $25. Additionally, the bill requires each contract between a health carrier (e.g., insurer or HMO) and a pharmacy benefits manager (PBM) that requires the PBM to administer a health care plan’s pharmacy benefits on the carrier’s behalf to also require the PBM to include at least one
covered epinephrine cartridge injector in the lowest cost-sharing tier if it uses a tiered prescription drug formulary.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found